156 related articles for article (PubMed ID: 28650)
1. Salazopyrin in rheumatoid arthritis.
McConkey B; Amos RS; Butler EP; Crockson RA; Crockson AP; Walsh L
Agents Actions; 1978 Jun; 8(4):438-41. PubMed ID: 28650
[TBL] [Abstract][Full Text] [Related]
2. Sulphasalazine in rheumatoid arthritis.
McConkey B; Amos RS; Durham S; Forster PJ; Hubball S; Walsh L
Br Med J; 1980 Feb; 280(6212):442-4. PubMed ID: 6102877
[TBL] [Abstract][Full Text] [Related]
3. Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group.
J Rheumatol; 1992 Nov; 19(11):1672-7. PubMed ID: 1362778
[TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
Martin L; Sitar DS; Chalmers IM; Hunter T
J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
[TBL] [Abstract][Full Text] [Related]
5. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
[TBL] [Abstract][Full Text] [Related]
6. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
Porter D; Madhok R; Hunter JA; Capell HA
Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
[TBL] [Abstract][Full Text] [Related]
7. [Sulfasalazine in rheumatoid arthritis].
Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
[TBL] [Abstract][Full Text] [Related]
8. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis].
Winkler V
Orv Hetil; 1986 Aug; 127(34):2073-4, 2079-80. PubMed ID: 2876405
[No Abstract] [Full Text] [Related]
9. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.
Williams HJ; Ward JR; Dahl SL; Clegg DO; Willkens RF; Oglesby T; Weisman MH; Schlegel S; Michaels RM; Luggen ME
Arthritis Rheum; 1988 Jun; 31(6):702-13. PubMed ID: 2898244
[TBL] [Abstract][Full Text] [Related]
10. [Pharmachem's salazopyrine in rheumatoid arthritis].
Konstantinova M; Konstantinova V
Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
Situnayake RD; McConkey B
J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
[TBL] [Abstract][Full Text] [Related]
12. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.
Farr M; Waterhouse L; Johnson AE; Kitas GD; Jubb RW; Bacon PA
Clin Rheumatol; 1995 Sep; 14(5):531-6. PubMed ID: 8549091
[No Abstract] [Full Text] [Related]
13. Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.
Delamere JP; Farr M; Grindulis KA
Br Med J (Clin Res Ed); 1983 May; 286(6377):1547-8. PubMed ID: 6133577
[No Abstract] [Full Text] [Related]
14. Treatment of early rheumatoid arthritis with rifampicin.
Cox NL; Prowse MV; Maddison MC; Maddison PJ
Ann Rheum Dis; 1992 Jan; 51(1):32-4. PubMed ID: 1540033
[TBL] [Abstract][Full Text] [Related]
15. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
[TBL] [Abstract][Full Text] [Related]
16. Long term experience of salazopyrin EN in rheumatoid arthritis (RA).
Farr M; Bacon PA; Coppock J; Scott DL
Scand J Rheumatol Suppl; 1987; 64():37-47. PubMed ID: 2893451
[TBL] [Abstract][Full Text] [Related]
17. Sulfasalazine: a review of its use in the management of rheumatoid arthritis.
Plosker GL; Croom KF
Drugs; 2005; 65(13):1825-49. PubMed ID: 16114981
[TBL] [Abstract][Full Text] [Related]
18. Additive triple DMARD combination therapy of a low dose of sulfhydryl compounds, sulfasalazine and methotrexate in the treatment of rheumatoid arthritis: a clinical trial.
Nishiya K; Hisakawa N; Tahara K; Matsumori A; Ito H; Hashimoto K; Nakatani K; Takatori K
Acta Med Okayama; 1999 Dec; 53(6):275-9. PubMed ID: 10631383
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
Crilly A; Madhok R; Watson J; Capell HA
Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
[TBL] [Abstract][Full Text] [Related]
20. A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
Hambardzumyan K; Saevarsdottir S; Forslind K; Petersson IF; Wallman JK; Ernestam S; Bolce RJ; van Vollenhoven RF
Arthritis Rheumatol; 2017 May; 69(5):953-963. PubMed ID: 27992691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
